Rapid Micro Biosystems (RPID) Expected to Announce Quarterly Earnings on Friday

Rapid Micro Biosystems (NASDAQ:RPID - Get Free Report) is projected to announce its Q1 2025 earnings results before the market opens on Friday, May 9th. Analysts expect the company to announce earnings of ($0.27) per share and revenue of $6.63 million for the quarter. Rapid Micro Biosystems has set its FY 2025 guidance at EPS.

Rapid Micro Biosystems (NASDAQ:RPID - Get Free Report) last posted its quarterly earnings data on Friday, February 28th. The company reported ($0.22) earnings per share for the quarter, meeting the consensus estimate of ($0.22). Rapid Micro Biosystems had a negative return on equity of 48.05% and a negative net margin of 184.93%. The business had revenue of $8.22 million during the quarter, compared to the consensus estimate of $8.20 million. On average, analysts expect Rapid Micro Biosystems to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Rapid Micro Biosystems Trading Down 3.0 %

RPID stock traded down $0.07 on Friday, hitting $2.25. The company's stock had a trading volume of 204,608 shares, compared to its average volume of 182,056. The stock has a market cap of $97.28 million, a price-to-earnings ratio of -2.01 and a beta of 1.12. The firm has a 50 day moving average of $2.50 and a two-hundred day moving average of $1.74. Rapid Micro Biosystems has a 1 year low of $0.58 and a 1 year high of $4.04.

Wall Street Analyst Weigh In

Separately, KeyCorp began coverage on shares of Rapid Micro Biosystems in a research note on Wednesday, February 12th. They set an "overweight" rating and a $8.00 target price for the company.

Rapid Micro Biosystems Company Profile

Rapid Micro Biosystems, Inc, a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services.